Industries > Pharma > Global Neuromodulation Devices Report 2020-2030

Back to Pharma Reports

Global Neuromodulation Devices Report 2020-2030

Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications and leading companies analysis in Neuromodulation Devices

PUBLISHED: 30 April 2020

PAGES: 238

PRODUCT CODE: PHA0715

SUBMARKET: Medical Devices Next Generation Technologies

SKU: PHA0715 Categories: Medical Devices, Next Generation Technologies, Pharma Tag: PHA0715

The neuromodulation devices market is estimated to grow at a CAGR of 12.1% over the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 238-page report you will receive 130 charts– all unavailable elsewhere.

The 238-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Neuromodulation Devices market forecasts from 2020-2030

• This report also breaks down the revenue forecast for the global neuromodulation devices market by type:
• Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
• Gastric Electrical Stimulation (GES)
• Other Applications

This report discusses the market trends and lists the leading products/pipeline products of each submarket.

• This report provides individual revenue forecasts to 2030 for these regional and national markets:
• North America: the US and Canada
• Europe: France, Germany, Italy, U.K, Spain, Russia, Netherlands, Switzerland, Belgium, Austria, Rest of Europe
• Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific
• Latin America: Brazil, Mexico, Argentina, Rest of Latin America
• Rest of the World: Middle East, Africa

Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

• Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.

• Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry:
• Medtronic
• Boston Scientific
• Abbott Laboratories
• LivaNova PLC
• & Other Companies

Visiongain’s study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.

Buy our report today Global Neuromodulation Devices Report 2020-2030: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1 Overview of the World Market for Neuromodulation Devices

1.2 Why You Should Read This Report

1.3 How this Report Delivers

1.4 Main Questions Answered by this Analysis

1.5 Who is this Report For?

1.6 Methodology

1.7 Frequently Asked Questions (FAQ)

1.8 Associated Visiongain Reports

1.9 About Visiongain

2. Introduction to Neuromodulation

2.1 Neuromodulation

2.2 Techniques Used in Neuromodulation

2.2.1 Electrical Stimulation Techniques

2.2.2 Pharmacological Therapy

2.3 Application of Neuromodulation

2.3.1 Pain

2.3.2 Depression

2.3.3 Epilepsy

2.3.4 Faecal and Urinary Incontinence

2.3.5 Hearing Disorders – Profound Deafness

2.3.6 Cardiovascular Diseases – Arrhythmia and Angina

3. Global Neuromodulation Devices Market 2018-2028

3.1 Neuromodulation Devices Market: 2018

3.2 Neuromodulation Devices Market Forecast by Type: 2018-2028

3.3 Neuromodulation Devices Market Forecast by Region: 2018-2028

3.4 Neuromodulation Devices: Industry Trends, 2018-2028

3.4.1 Industry Trends - Ageing Population

3.4.2 Rising Prevalence of Chronic Diseases

3.4.3 Industry Trends – Personalised Healthcare

3.4.4 Industry Trends – National Regulations

3.4.5 Political Uncertainty and Security Risk across the World

3.4.6 Industry Trends – Economic Challenges

3.4.7 Industry Trends – Mergers and Acquisitions

4. Spinal Cord Stimulation Submarket, 2018-2028

4.1 Spinal Cord Stimulation (SCS) Market Overview, 2018

4.2 SCS Market Forecast: 2018-2028

4.3 Top Selling & Pipeline SCS Devices, 2018

4.4 Applications of Spinal Cord Stimulation

4.5 SCS Market Trends: 2018-2028

5. Deep Brain Stimulation Submarket, 2018-2028

5.1 Deep Brain Stimulation (DBS) Market Overview, 2018

5.2 DBS Market Forecast: 2018-2028

5.3 Top Selling & Pipeline DBS Devices, 2018

5.4 Applications of Deep Brain Stimulation

5.5 DBS Market Trends: 2018-2028

6. Gastric Electrical Stimulation Submarket, 2018-2028

6.1 Gastric Electrical Stimulation (GES) Market Overview, 2018

6.2 GES Market Forecast: 2018-2028

6.3 Top Selling GES Devices, 2018

6.4 Applications of Gastric Electrical Stimulation

6.5 GES Market Trends: 2018-2028

7. Vagus Nerve Stimulation Submarket, 2018-2028

7.1 Vagus Nerve Stimulation (VNS) Market Overview, 2018

7.2 VNS Market Forecast: 2018-2028

7.3 Top Selling & Pipeline VNS Devices, 2018

7.4 Applications of Vagus Nerve Stimulation

7.5 VNS Market Trends: 2018-2028

8. Sacral Nerve Stimulation Submarket, 2018-2028

8.1 Sacral Nerve Stimulation (SNS) Market Overview, 2018

8.2 SNS Market Forecast: 2018-2028

8.3 Top Selling & Pipeline SNS Devices, 2018

8.4 Applications of Sacral Nerve Stimulation

8.5 SNS Market Trends: 2018-2028

9. Other Neuromodulation Technologies Submarket, 2018-2028

9.1 Other Neuromodulation Technologies Overview, 2018

9.1.1 Trigeminal Nerve Stimulation

9.1.2 Cochlear Implants

9.1.3 Transcranial Magnetic Stimulation (TMS)

9.1.4 Transcranial Direct Current Stimulation (tDCS)

9.1.5 Ultrasonic Neuromodulation

9.2 Other Neuromodulation Techniques Forecast: 2018-2028

10. North American Neuromodulation Devices Market 2018-2028

10.1 Overview: North American Neuromodulation Devices Market 2018

10.2 The US Neuromodulation Devices Market: 2018-2028

10.2.1 The US Neuromodulation Devices Market Forecast: 2018-2028

10.3 The Canadian Neuromodulation Devices Market: 2018-2028

10.3.1 The Canadian Neuromodulation Devices Market Forecast: 2018-2028

11. Latin American Neuromodulation Devices Market 2018-2028

11.1 Overview: Latin American Neuromodulation Devices Market 2018

11.2 The Brazilian Neuromodulation Devices Market: 2018-2028

11.2.1 The Brazilian Neuromodulation Devices Market: Economic and Political Challenges Affecting Prospects

11.2.2 The Brazilian Neuromodulation Devices Market Forecast: 2018-2028

11.3 The Mexican Neuromodulation Devices Market: 2018-2028

11.3.1 The Mexican Neuromodulation Devices Market Forecast: 2018-2028

11.4 The rest of Latin America Neuromodulation Devices Market: 2018-2028

11.4.1 The rest of Latin America Neuromodulation Devices Market Forecast: 2018-2028

12. European Neuromodulation Devices Market 2018-2028

12.1 Overview: European Neuromodulation Devices Market 2018

12.2 The German Neuromodulation Devices Market: 2018-2028

12.2.1 The German Neuromodulation Devices Market Forecast: 2018-2028

12.3 The French Neuromodulation Devices Market: 2018-2028

12.3.1 The French Neuromodulation Devices Market – the Economy and its Implications

12.3.2 The French Neuromodulation Devices Market Forecast: 2018-2028

12.4 The UK Neuromodulation Devices Market: 2018-2028

12.4.1 The UK Neuromodulation Devices Market Forecast - Political Challenges

12.4.2 The UK Neuromodulation Devices Market Forecast: 2018-2028

12.5 The Italian Neuromodulation Devices Market: 2018-2028

12.5.1 The Italian Neuromodulation Devices Market Outlook

12.5.2 The Italian Neuromodulation Devices Market Forecast: 2018-2028

12.6 The Spanish Neuromodulation Devices Market: 2018-2028

12.6.1 The Spanish Neuromodulation Devices Market Forecast: 2018-2028

12.7 The Russian Neuromodulation Devices Market: 2018-2028

12.7.1 The Russian Neuromodulation Devices Market Forecast: 2018-2028

12.8 The rest of European Neuromodulation Devices Market: 2018-2028

12.8.1 The rest of European Neuromodulation Devices Market Forecast: 2018-2028

13. Asia-Pacific Neuromodulation Devices Market 2018-2028

13.1 Overview: Asia-Pacific Neuromodulation Devices Market 2018

13.2 The Japanese Neuromodulation Devices Market: 2018-2028

13.2.1 The Japanese Neuromodulation Devices Market –Regulation Effects

13.2.2 The Japanese Neuromodulation Devices Market Forecast: 2018-2028

13.3 The Chinese Neuromodulation Devices Market: 2018-2028

13.3.1 The Chinese Neuromodulation Devices Market – Amendments to Regulations

13.3.2 The Chinese Neuromodulation Devices Market Forecast: 2018-2028

13.4 The Indian Neuromodulation Devices Market: 2018-2028

13.4.1 The Indian Neuromodulation Devices Market Forecast: 2018-2028

13.5 The Australian Neuromodulation Devices Market: 2018-2028

13.5.1 The Australian Neuromodulation Devices Market Forecast: 2018-2028

13.6 The South-Korean Neuromodulation Devices Market: 2018-2028

13.6.1 The South-Korean Neuromodulation Devices Market Forecast: 2018-2028

13.7 The rest of Asia-Pacific Neuromodulation Devices Market: 2018-2028

13.7.1 The rest of Asia-Pacific Neuromodulation Devices Market Forecast: 2018-2028

14. Rest of the world Neuromodulation Devices Market 2018-2028

14.1 Overview: Rest of the world Neuromodulation Devices Market 2018

14.2 The Middle-Eastern Neuromodulation Devices Market: 2018-2028

14.2.1 The Middle-Eastern Neuromodulation Devices Market Forecast: 2018-2028

14.3 The African Neuromodulation Devices Market: 2018-2028

14.3.1 The African Neuromodulation Devices Market Forecast: 2018-2028

15. Neuromodulation Devices Market: Manufacturers

15.1 Medtronic

15.1.1 Sales and Recent Performance Analysis, 2017

15.1.2 Medtronic International Operations

15.1.3 Medtronic News

15.1.4 Medtronic Market Outlook

15.2 Boston Scientific Corporation

15.2.1 Sales and Recent Performance Analysis: 2017

15.2.2 Boston Scientific International Operations

15.2.3 Boston Scientific-Neuromodulation Performance

15.2.4 Boston Scientific News

15.2.5 Boston Scientific Market Outlook

15.3 St. Jude Medical (SJM) (now an Abbott company)

15.3.1 Sales and Recent Performance Analysis: 2016

15.3.2 Abbott International Operations, 2017

15.3.3 Abbot/ SJM News

15.3.4 SJM - Market Outlook

15.4 Cyberonics (now a LivaNova Company)

15.4.1 Sales and Recent Performance Analysis: 2017

15.4.2 LivaNova Company International Operations

15.4.3 Cyberonics News

15.4.4 Cyberonics (LivaNova) Market Outlook

15.5 Other Companies

15.5.1 Stryker Corporation

15.5.2 Nevro Corp.

15.5.2.1 Nevro Corp News.

15.5.3 SetPoint Medical

15.5.4 Functional Neuromodulation

15.5.5 Neurotherapies Reset

15.5.6 Wiringless Implantable Stretchable Electronics (WISE)

15.5.7 SceneRay

15.5.8 Mindray

16. Qualitative Analysis of the Neuromodulation Devices Market, 2017

16.1 SWOT Analysis of the Neuromodulation Devices Market

16.1.1 Strengths of the Market

16.1.2 Weaknesses

16.1.3 Opportunities in the Neuromodulation Devices Market

16.1.4 Threats Facing the Neuromodulation Devices Market

16.2 STEP Analysis of the Neuromodulation Devices Market

16.2.1 Social Factors: The Role of Neuroethics

16.2.2 Technological Developments: Drive towards Non-Invasive Methods

16.2.3 Economic Restraints: High Production Costs

16.2.4 Economic Potential: Emerging Markets Create Demand

16.2.5 Political Issues: Strong Government Influence

16.3 Snapshot of Companies in Active Clinical Trials

16.3.1 Neuromodulation Pipeline Products -2016-2018

17. Conclusions

17.1 The United States Retains its Position as Market Leader

17.2 Growing Incidences of Neurological Diseases

17.3 Ageing Population Drives Growth

17.4 China and India will lead the Emerging Markets

17.5 The Future of the Market - Deep Brain Stimulation and Vagus Nerve Stimulation

17.6 Concluding Remarks

Appendices

Associated Visiongain Reports

Visiongain Report Sales Order Form

Appendix A

About Visiongain

Appendix B

Visiongain Report Evaluation Form

List of Tables

Table 3.1 Global Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 3.2 Global Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 4.1 SCS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 4.2 Leading & Pipeline SCS Devices, 2018

Table 5.1 DBS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 5.2 Leading & Pipeline DBS Devices, 2018

Table 6.1 GES Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 6.2 Leading GES Devices, 2018

Table 7.1 VNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 7.2 Leading VNS & Pipeline Devices, 2018

Table 8.1 SNS Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 8.2 Leading & Pipeline SNS Devices, 2018

Table 9.1 Leading & Pipeline Other Neuromodulation Devices, 2018

Table 9.2 Other Neuromodulation Devices Market: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 10.1 North American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 10.2 North American Neuromodulation Devices Market by type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 10.3 The US Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 10.4 The Canadian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 11.1 Latin American Neuromodulation Devices Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 11.2 Latin American Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 11.3 The Brazilian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 11.4 The Mexican Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 11.5 The rest of Latin America Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.1 European Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.2 European Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.3 The German Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.4 The French Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.5 The UK Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.6 The Italian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.7 The Spanish Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.8 The Russian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 12.9 The rest of European Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.1 Asia-Pacific Neuromodulation Devices Market, by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.2 Asia-Pacific Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.3 The Japanese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.4 The Chinese Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.5 The Indian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.6 The Australian Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.7 The South-Korean Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 13.8 The rest of Asia-Pacific Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 14.1 Rest of the world Neuromodulation Devices Market by Country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 14.2 Rest of the world Neuromodulation Devices Market by Type: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 14.3 The Middle-Eastern Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 14.4 The African Neuromodulation Devices Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2018-2028

Table 16.1 Companies in Active Clinical Trials 2018-2028

List of Figures

Figure 1.1 Neuromodulation Devices Market Segmentation, 2018

Figure 3.1 Global Neuromodulation Devices Market by Type: Market Share (%) 2018

Figure 3.2 Global Neuromodulation Devices Market by Type: Market Share (%) 2028

Figure.3.3 Global Neuromodulation Devices Market by Country: Market Share (%) 2018

Figure 3.4 Global Neuromodulation Devices Market by Country: Market Share (%) 2028

Figure 3.5 Global Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 3.6 Global Neuromodulation Devices Market: Drivers and Restraints

Figure 4.1 SCS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 5.1 DBS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 6.1 GES Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 7.1 VNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 8.1 SNS Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 9.1 Other Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 10.1 North American Neuromodulation Devices Market by Country: Market Share (%) 2018

Figure 10.2 North American Neuromodulation Devices Market by Country: Market Share (%)2028

Figure 10.3 North American Neuromodulation Devices Market by Type: Market Share (%) 2018

Figure 10.4 North American Neuromodulation Devices Market by Type: Market Share (%)2028

Figure 10.5 North American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 10.6 The US Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 10.7 The Canadian Neuromodulation Devices Market Revenue Forecast ($m) AGR (%), 2018-2028

Figure 11.1 Latin American Neuromodulation Devices Market by Country: Market Share (%) 2018

Figure 11.2 Latin American Neuromodulation Devices Market by Country: Market Share (%) 2028

Figure 11.3 Latin American Neuromodulation Devices Market by Type: Market Share (%) 2018

Figure 11.4 Latin American Neuromodulation Devices Market by Type: Market Share (%) 2028

Figure 11.5 Latin American Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 11.6 The Brazilian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Fig 11.7 The Mexican Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 11.8 The rest of Latin America Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.1 European Neuromodulation Devices Market by Country: Market Share (%) 2018

Figure 12.2 European Neuromodulation Devices Market by Country: Market Share (%) 2028

Figure 12.3 European Neuromodulation Devices Market by Type: Market Share (%) 2018

Figure 12.4 European Neuromodulation Devices Market by Type: Market Share (%) 2028

Figure 12.5 European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.6 The German Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.7 The French Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.8 The UK Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.9 The Italian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.10 The Spanish Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.11 The Russian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 12.12 The rest of European Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 13.1 Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2018

Figure 13.2 Asia-Pacific Neuromodulation Devices Market by Country: Market Share (%) 2028

Figure 13.3 Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2018

Figure 13.4 Asia-Pacific Neuromodulation Devices Market by Type: Market Share (%) 2028

Figure 13.5 Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 13.6 The Japanese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure13.7 The Chinese Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 13.8 The Indian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 13.9 The Australian Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 13.10 The South-Korean Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 13.11 The rest of Asia-Pacific Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 14.1 Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2018

Figure 14.2 Rest of the world Neuromodulation Devices Market by Country: Market Share (%) 2028

Figure 14.3 Rest of the world Neuromodulation Devices Market by Type: Market Share (%) 2018

Figure 14.4 Rest of the world Neuromodulation Devices Market, by type: Market Share (%)2028

Figure 14.5 Rest of the world Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 14.6 The Middle-Eastern Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 14.7 The African Neuromodulation Devices Market Revenue Forecast ($m), AGR (%), 2018-2028

Figure 15.1 Neuromodulation Devices Market: Market Share Analysis, 2016

Figure 15.2 Medtronic Revenue ($m), 2013-2017

Figure 15.3 Medtronic Operating Sectors (%), 2017

Figure 15.4 Medtronic Sales Shares (%), 2017

Figure 15.5 Boston Scientific Revenues ($m), 2013-2017

Figure 15.6 Boston Scientific Operating Sectors (%), 2017

Figure 15.7 Boston Scientific Sector Shares (%), 2017

Figure 15.8 Boston Scientific World Sales Shares (%), 2017

Figure 15.9 Boston Scientific Geographical Sales Shares (%), 2017

Figure 15.10 Boston Scientific Neuromodulation Historical Revenue ($m), 2015-2017

Figure 15.11 Boston Scientific Neuromodulation Revenue Shares (%) within Med-Surgical Sector, 2016

Figure 15.12 Abbott/ St. Jude Neuromodulation Revenues ($m), 2016

Figure 15.13 Abbott Operating Sectors (%) (2017)

Figure 15.14 Cardiovascular and Neuromodulation Operating Sectors (%), 2017

Figure 15.15 Abbott World Sales Shares (%), 2017

Figure 15.16 LivaNova Company Revenues ($m), 2015-2017

Figure 15.17 LivaNova Company Operating Sectors (%) (2017)

Figure 15.18 LivaNova World Sales for Neuromodulation Devices Shares (%), 2017

Figure 15.19 Nevro Corp. Revenue ($m), 2017

Figure 15.20 Nevro Corp World Sales for Neuromodulation Devices Shares (%), 2017

Figure 16.1 SWOT Analysis of the Neuromodulation Devices Market, 2017

Figure 16.2 STEP Analysis of the Neuromodulation Devices Market, 2017

Abbott Laboratories

Advanced Uro-Solutions

Aleva Neurotherapeutics

Atrotech

Autonomic Technologies

Avery Biomedical

Axonics Modulation

BioControl Medical

Bioness, Inc.

BlueWind

Boston Scientific

CardioMEMS

CerebralRx

CerebroMed

Cogentix Medical

Covidien

CVRx, Inc

Deep Brain Innovations

Dymedix Corporation

ElectroCore INC

EndoNovo

EnteroMedics

Functional Neuromodulation

Genesys Capital

GlaxoSmithKline

Greatbatch

Halo Neuroscience

ImThera Medical

InCube Labs

InSightec

Integer Holdings Corporation

Jens Brøndum Frøkjær

Laborie Medical Technologies

Lake Region Medical

LivaNova

MagStim

MainStay Medical

Mayo Clinic

Medtronic

Medtronic Eindhoven Design Centre (MEDC)

Medtronic France SAS

MedtronicNeuro

MetaCure

Microtransponder

Mindray

MyndTec Inc.

Nanostim

NDI Medical

NeuImpulse

Neuromod Devices Ltd

NeuroPace

NeuroSigma

NeuroStar

Neurotherapies Reset

NeuroTherm

NeuroVista Corp

NeuSpera

Nevro

Newronika

Nexstim plc

Northwell Health

nUro Inc

Nuvectra Corporation

QiG Group,LLC

SceneRay

Scion NeuroStim

SetPoint Medical

SorinSpA

Soterix Medical

Spinal Modulation Inc

SPR Therapeutics

St. Jude Medical

Stimwave

Synapse Medical

The Neuroscience Center, LLC

Theranova, L.L.C.

TriHealth Inc.

Urolplasty

List of Companies Mentioned in the Report

Aalborg University Hospital

Australia Institute of Health and Welfare

China Food and Drug Administration (CFDA)

Dutch National Health Care Institute

Food and Drug Administtration (FDA)

Foundation Medical Partners

Gaceta Médica de México

Genesys Capital

Health Canada

Maastricht University Medical Center

National Institute for Health and Care Excellence (NICE)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Nordic Neuromodulation Society

North American Neuromodulation Society (NANS)

Northern California Institute of Research and Education

Organization for Economic Cooperation and Development (OECD)

Pharmaceuticals and Medical Devices Agency (PMDA)

University Hospital Regensburg

World Health Organization (WHO)

Download sample pages

Complete the form below to download your free sample pages for Global Neuromodulation Devices Report 2020-2030

Download sample pages

Complete the form below to download your free sample pages for Global Neuromodulation Devices Report 2020-2030

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.

20 March 2023

READ

Visiongain Publishes eClinical Solutions Market Report 2023-2033

The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.

17 March 2023

READ

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.

15 March 2023

READ

Visiongain Publishes Regenerative Medicine Market Report 2023-2033

The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.

10 March 2023

READ

Industries > Pharma > Global Neuromodulation Devices Report 2020-2030

Back to Pharma Reports

Global Neuromodulation Devices Report 2020-2030

Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications and leading companies analysis in Neuromodulation Devices

Download sample pages

Related reports

Global Precision Medicine Market Forecast 2019-2029

The Global Respiratory Inhalers Market 2020-2030

Global Spinal Cord Stimulation Devices Market Forecast 2020-2030

Global Neurostimulation Devices Market 2019-2029

Global Ophthalmic Devices Market 2020-2030

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

Visiongain Publishes eClinical Solutions Market Report 2023-2033

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

Visiongain Publishes Regenerative Medicine Market Report 2023-2033

Our Clients